Ostatní
Návod 
Viatris Inc.
VTRS
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
11.6B
Obrat
14B
Zisk
-4B
Aktiva
38B
Dluh
15B
ROE
-24%
ROA
-10%
PE
-4
PS
1
Cena 1R
7-13
⌀ Cena
9.85
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
26-02-2026
Poslední dividenda
24-11-2025
Profil
Viatris Inc. působí jako zdravotnická společnost po celém světě. Společnost působí ve čtyřech segmentech: Rozvinuté trhy, Velká Čína, JANZ a Rozvíjející se trhy. Nabízí značkové léky na předpis, generické léky, komplexní generické léky, biosimilary a aktivní farmaceutické složky (API). Společnost nabízí léky v různých terapeutických oblastech, včetně nepřenosných a infekčních nemocí; biosimilary v oblasti onkologie, imunologie, endokrinologie, oftalmologie a dermatologie; a API pro antibakteriální a centrální nervový systém, antihistaminika/antiastmatika, kardiovaskulární, antidiabetika, antimykotika a inhibitory protonové pumpy, jakož i podpůrné služby, jako jsou diagnostické kliniky, vzdělávací semináře a digitální nástroje, které pomáhají pacientům lépe zvládat jejich zdraví. Poskytuje své léčivé přípravky ve formě perorálních pevných dávek, injekčních tablet, komplexních lékových forem a API maloobchodním a lékárenským zařízením, velkoobchodníkům a distributorům, plátcům, pojišťovnám a vládám a institucím. Společnost distribuuje své produkty prostřednictvím velkoobchodníků s farmaceutickými výrobky, maloobchodníků s farmaceutickými výrobky, institucionálních lékáren, zásilkových a elektronických lékáren a specializovaných lékáren. Prodává své produkty pod názvy Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine a Yupelri; Norvasc a Viagra; AMITIZA, Lipacreon a Effexor; a Celebrex a ARV, stejně jako nabízí biosimilární franšízy, včetně Fulphila, Ogivri, Hulio a SEMGLEE. Společnost má spolupráci a licenční smlouvy s Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; Biocon Ltd.; a Fujifilm Kyowa Kirin Biologics Co. Ltd. Viatris Inc. byla založena v roce 1961 a sídlí v Canonsburgu, Pennsylvania.
Sektor
Healthcare
Odvětví
Drug Manufacturers - Specialty & Generic
Počet zaměstnanců
32000
Založení
1980-03-17
Podobné společnosti
$ 13.49
+ $ 0.03
$ 23.89
- $ 0.66
$ 22.10
+ $ 0.61
$ 66.56
+ $ 0.38
$ 17.74
- $ 0.27
$ 147.28
- $ 5.09
$ 20.80
+ $ 0.18
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliardách (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 14.30 | 14.30 | 14.74 | 15.43 | 16.26 | 17.89 | 11.95 | 11.50 | 11.43 | 11.91 | 11.08 | 9.43 | 7.72 | 6.91 | 6.80 | 6.13 | 5.45 | |
| Cost of Revenues | 9.29 | 9.29 | 9.12 | 8.99 | 9.77 | 12.31 | 8.15 | 7.60 | 7.43 | 7.12 | 6.38 | 5.21 | 4.19 | 3.87 | 3.89 | 3.57 | 3.23 | |
| Gross Profit | 5.01 | 5.01 | 5.62 | 6.44 | 6.50 | 5.58 | 3.80 | 3.90 | 4.00 | 4.78 | 4.70 | 4.22 | 3.53 | 3.04 | 2.91 | 2.56 | 2.22 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 3.70 | 3.76 | 3.58 | 3.25 | 3.53 | 3.75 | 3.80 | 3.66 | 3.84 | 3.94 | |
| Cost of Revenues | 2.57 | 2.38 | 2.25 | 2.09 | 2.31 | 2.29 | 2.35 | 2.16 | 2.24 | 2.25 | |
| Gross Profit | 1.13 | 1.38 | 1.33 | 1.16 | 1.22 | 1.46 | 1.45 | 1.50 | 1.60 | 1.69 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.91 | 0.66 | 0.75 | 0.56 | 0.64 | 0.70 | 0.78 | 0.83 | 0.67 | 0.58 | 0.51 | 0.40 | 0.29 | 0.28 | |
| Selling General & Admin Expenses | 0.00 | 0.00 | 0.00 | 4.65 | 4.18 | 4.53 | 3.34 | 2.56 | 2.44 | 2.58 | 2.50 | 2.18 | 1.63 | 1.41 | 1.40 | 1.21 | 1.09 | |
| Depreciation & Amortization | 2.80 | 2.80 | 2.89 | 2.68 | 3.03 | 4.51 | 2.22 | 2.02 | 2.11 | 1.81 | 1.52 | 1.03 | 0.57 | 0.52 | 0.55 | 0.51 | 0.42 | |
| Total Operating Expenses | 7.68 | 7.68 | 5.61 | 5.67 | 4.84 | 5.28 | 3.90 | 3.20 | 3.15 | 3.36 | 3.32 | 2.85 | 2.13 | 1.92 | 1.80 | 1.51 | 1.37 | |
| Operating Income | -2.66 | -2.66 | 0.01 | 0.77 | 0.42 | -4.21 | -0.11 | -1.37 | 0.91 | 1.44 | 0.70 | 1.46 | 1.35 | 1.14 | 1.11 | 1.01 | 0.72 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.20 | 0.21 | ||
| Selling General & Admin Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.61 | 1.05 | ||
| Depreciation & Amortization | 0.77 | 0.69 | 0.68 | 0.66 | 0.75 | 0.67 | 0.79 | 0.69 | 0.64 | 0.68 | ||
| Total Operating Expenses | 1.40 | 1.13 | 1.10 | 4.04 | 1.39 | 1.23 | 1.69 | 1.30 | 1.81 | 1.26 | ||
| Operating Income | -0.27 | 0.25 | 0.23 | -2.88 | -0.18 | 0.23 | -0.24 | 0.20 | -0.45 | 0.45 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 0.47 | 0.47 | 0.55 | 0.57 | 0.59 | 0.64 | 0.50 | 0.52 | 0.54 | 0.53 | 0.45 | 0.34 | 0.33 | 0.31 | 0.31 | 0.34 | 0.33 | |
| Other Expense | -1.00 | -1.00 | -0.63 | -0.56 | 2.39 | 3.54 | -0.61 | 1.52 | -0.02 | 0.01 | -0.80 | -0.11 | -0.09 | -0.06 | 0.01 | -0.06 | -0.16 | |
| IBT | -3.67 | -3.67 | -0.62 | 0.20 | 2.81 | -0.66 | -0.72 | 0.15 | 0.30 | 0.90 | 0.12 | 0.92 | 0.97 | 0.75 | 0.80 | 0.65 | 0.36 | |
| Income Tax Expense | -0.15 | -0.15 | 0.01 | 0.15 | 0.73 | 0.60 | -0.05 | 0.14 | -0.05 | 0.21 | -0.36 | 0.07 | 0.04 | 0.12 | 0.16 | 0.12 | 0.01 | |
| Net Income | -3.51 | -3.51 | -0.63 | 0.05 | 2.08 | -1.27 | -0.67 | 0.02 | 0.35 | 0.70 | 0.48 | 0.85 | 0.93 | 0.62 | 0.64 | 0.54 | 0.35 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Interest Expense | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | 0.15 | 0.15 | 0.14 | 0.14 | 0.14 | ||
| Other Expense | -0.08 | -0.26 | -0.45 | -0.21 | -0.35 | -0.14 | -0.15 | 0.00 | -0.40 | -0.05 | ||
| IBT | -0.34 | -0.01 | -0.22 | -3.10 | -0.53 | 0.09 | -0.39 | 0.20 | -0.86 | 0.40 | ||
| Income Tax Expense | 0.00 | 0.12 | -0.21 | -0.06 | -0.01 | 0.00 | -0.07 | 0.09 | -0.09 | 0.07 | ||
| Net Income | -0.34 | -0.13 | 0.00 | -3.04 | -0.52 | 0.09 | -0.33 | 0.11 | -0.77 | 0.33 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.05 | $1.71 | $-1.05 | $-1.11 | $0.03 | $0.69 | $1.30 | $0.94 | $1.80 | $2.49 | $1.63 | $1.54 | $1.25 | $0.69 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.05 | $1.71 | $-1.05 | $-1.11 | $0.03 | $0.68 | $1.30 | $0.92 | $1.70 | $2.34 | $1.58 | $1.52 | $1.22 | $0.68 | |
| Shares Outstanding | 1.15 | 1.17 | 1.19 | 1.20 | 1.21 | 1.21 | 0.60 | 0.52 | 0.51 | 0.53 | 0.51 | 0.47 | 0.37 | 0.38 | 0.42 | 0.43 | 0.32 | |
| Diluted Shares Outstanding | 1.15 | 1.17 | 1.19 | 1.21 | 1.22 | 1.21 | 0.60 | 0.52 | 0.52 | 0.54 | 0.52 | 0.50 | 0.40 | 0.39 | 0.42 | 0.44 | 0.33 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.64 | $0.28 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.64 | $0.27 | ||
| Shares Outstanding | 1.15 | 1.16 | 1.17 | 1.19 | 1.19 | 1.19 | 1.19 | 1.20 | 1.20 | 1.20 | ||
| Diluted Shares Outstanding | 1.15 | 1.16 | 1.17 | 1.19 | 1.19 | 1.20 | 1.19 | 1.21 | 1.20 | 1.21 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 0.92 | 0.73 | 0.99 | 1.26 | 0.70 | 0.84 | 0.48 | 0.39 | 0.29 | 1.00 | 1.24 | 0.23 | 0.29 | 0.35 | 0.38 | 0.66 | |
| Short Term Investments | 0.09 | 0.36 | 0.19 | 0.21 | 0.23 | 0.20 | 0.11 | 0.09 | 0.20 | 0.18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.03 | |
| Total Cash & ST Investments | 1.01 | 1.09 | 1.18 | 1.26 | 0.70 | 1.05 | 0.48 | 0.39 | 0.29 | 1.00 | 1.24 | 0.23 | 0.29 | 0.35 | 0.41 | 0.69 | |
| Accounts Receivable | 3.86 | 3.52 | 4.04 | 3.81 | 4.27 | 4.84 | 3.06 | 2.88 | 3.61 | 3.31 | 2.69 | 2.27 | 1.82 | 1.55 | 1.43 | 1.16 | |
| Inventory | 3.94 | 3.85 | 3.47 | 3.52 | 3.98 | 5.47 | 2.67 | 2.58 | 2.54 | 2.46 | 1.95 | 1.65 | 1.66 | 1.53 | 1.40 | 1.24 | |
| Other Current Assets | 2.33 | 1.05 | 4.28 | 1.81 | 1.96 | 1.23 | 0.55 | 0.52 | 0.77 | 0.76 | 0.60 | 2.64 | 0.45 | 0.47 | 0.34 | 0.45 | |
| Total Current Assets | 11.14 | 9.52 | 12.98 | 10.64 | 10.90 | 12.87 | 6.76 | 6.37 | 7.21 | 7.52 | 6.47 | 6.79 | 4.47 | 3.90 | 3.57 | 3.56 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 1.00 | 0.57 | 0.76 | 0.73 | 1.88 | 0.92 | 1.01 | 0.99 | 1.31 | 0.63 | |
| Short Term Investments | 0.10 | 0.24 | 0.25 | 0.36 | 0.17 | 0.23 | 0.16 | 0.19 | 0.25 | 0.18 | |
| Total Cash & ST Investments | 1.11 | 0.81 | 1.00 | 1.09 | 2.05 | 1.14 | 1.18 | 1.18 | 1.56 | 0.81 | |
| Accounts Receivable | 3.59 | 3.60 | 3.39 | 3.52 | 3.94 | 3.86 | 3.94 | 4.04 | 3.74 | 3.61 | |
| Inventory | 4.11 | 4.26 | 4.10 | 3.85 | 4.08 | 3.94 | 3.82 | 3.47 | 3.67 | 3.64 | |
| Other Current Assets | 0.49 | 1.10 | 1.14 | 1.05 | 1.23 | 2.85 | 3.98 | 4.28 | 2.13 | 1.82 | |
| Total Current Assets | 9.29 | 9.77 | 9.62 | 9.52 | 11.31 | 11.79 | 12.92 | 12.98 | 10.93 | 9.78 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 2.94 | 2.92 | 3.01 | 3.28 | 3.48 | 3.78 | 2.40 | 2.17 | 2.34 | 2.32 | 1.98 | 1.79 | 1.66 | 1.40 | 1.30 | 1.21 | |
| Goodwill | 9.33 | 9.13 | 9.87 | 10.43 | 12.11 | 12.35 | 9.59 | 9.75 | 10.21 | 9.23 | 5.38 | 4.05 | 4.29 | 3.52 | 3.52 | 3.60 | |
| Intangible Assets | 18.42 | 17.07 | 19.18 | 22.61 | 26.13 | 29.68 | 11.65 | 13.66 | 15.25 | 14.45 | 7.22 | 2.35 | 2.52 | 2.22 | 2.63 | 2.50 | |
| Long-Term Investments | 1.44 | 1.35 | 1.14 | 1.09 | -4.81 | 0.05 | 0.09 | 0.14 | 0.23 | 0.40 | -2.44 | -1.87 | 0.00 | -1.48 | 0.00 | -1.27 | |
| Other Long-Term Assets | 1.38 | 0.75 | 0.82 | 1.05 | 5.69 | 0.68 | 0.06 | 0.07 | 0.08 | 0.17 | 3.19 | 2.70 | 2.22 | 2.29 | 0.54 | 1.88 | |
| Total Long-Term Assets | 34.19 | 31.98 | 34.71 | 39.39 | 43.94 | 48.69 | 24.50 | 26.37 | 28.59 | 27.20 | 15.80 | 9.10 | 10.77 | 8.03 | 8.03 | 7.98 | |
| Total Assets | 45.33 | 41.50 | 47.69 | 50.02 | 54.84 | 61.55 | 31.26 | 32.73 | 35.81 | 34.73 | 22.27 | 15.89 | 15.24 | 11.93 | 11.60 | 11.54 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 2.89 | 2.92 | 2.90 | 2.92 | 2.94 | 2.94 | 2.95 | 3.01 | 3.17 | 3.23 | |
| Goodwill | 6.73 | 6.75 | 6.46 | 9.13 | 9.56 | 9.33 | 9.69 | 9.87 | 10.28 | 10.53 | |
| Intangible Assets | 15.72 | 16.32 | 16.66 | 17.07 | 17.98 | 18.42 | 19.13 | 19.18 | 21.28 | 22.08 | |
| Long-Term Investments | 0.85 | 0.95 | 1.23 | 1.35 | 1.48 | 1.44 | 1.19 | 1.14 | 1.21 | 1.18 | |
| Other Long-Term Assets | 1.43 | 0.77 | 0.78 | 0.75 | 0.72 | 0.73 | 0.80 | 0.82 | 0.93 | 0.92 | |
| Total Long-Term Assets | 28.63 | 28.64 | 28.85 | 31.98 | 33.45 | 33.54 | 34.42 | 34.71 | 37.81 | 38.92 | |
| Total Assets | 37.92 | 38.41 | 38.47 | 41.50 | 44.75 | 45.33 | 47.34 | 47.69 | 48.74 | 48.70 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 1.38 | 1.36 | 1.38 | 1.16 | 1.06 | 1.35 | 1.06 | 1.12 | 0.98 | 0.94 | 1.11 | 0.91 | 1.07 | 0.78 | 0.70 | 0.56 | |
| Short-Term Debt | 2.46 | 0.09 | 2.02 | 1.26 | 1.88 | 3.45 | 1.51 | 0.70 | 1.81 | 0.29 | 1.08 | 2.81 | 0.44 | 0.40 | 0.82 | 0.17 | |
| Other Current Liabilities | 3.75 | 4.14 | 4.15 | 3.40 | 8.01 | 2.43 | 4.06 | 3.89 | 4.58 | 4.75 | 0.64 | 0.42 | 0.60 | 2.19 | 1.00 | 1.06 | |
| Current Liabilities | 7.71 | 5.78 | 7.78 | 6.75 | 9.88 | 10.56 | 5.57 | 4.59 | 6.39 | 5.04 | 4.12 | 5.31 | 2.96 | 2.19 | 2.56 | 1.81 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 1.33 | 1.32 | 1.52 | 1.36 | 1.24 | 1.38 | 1.58 | 1.38 | 1.22 | 1.31 | |
| Short-Term Debt | 2.06 | 1.78 | 0.10 | 0.09 | 1.53 | 2.46 | 1.98 | 2.02 | 1.39 | 1.43 | |
| Other Current Liabilities | 3.97 | 4.03 | 4.00 | 4.14 | 4.46 | 3.75 | 4.05 | 4.15 | 4.02 | 3.62 | |
| Current Liabilities | 7.36 | 7.13 | 5.72 | 5.78 | 7.51 | 7.71 | 7.76 | 7.78 | 6.83 | 6.52 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 14.73 | 14.22 | 16.35 | 18.02 | 19.72 | 22.66 | 11.21 | 13.16 | 12.87 | 15.20 | 6.30 | 5.73 | 7.59 | 5.34 | 4.48 | 5.26 | |
| Capital Leases | 0.19 | 0.27 | 0.25 | 0.26 | 0.29 | 0.32 | 0.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.77 | 0.00 | 0.00 | |
| Def. Tax Liability | 1.57 | 1.11 | 1.74 | 2.43 | 2.82 | 3.12 | 1.63 | 1.72 | 2.01 | 2.01 | 0.72 | 0.24 | 0.47 | 0.27 | 0.31 | 0.48 | |
| Total Liabilities | 25.81 | 22.87 | 27.22 | 28.95 | 34.35 | 38.60 | 19.37 | 20.57 | 22.50 | 23.61 | 12.50 | 12.61 | 12.28 | 8.58 | 8.09 | 7.92 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 12.66 | 12.97 | 14.35 | 14.22 | 14.49 | 14.92 | 16.23 | 16.35 | 17.24 | 17.41 | |
| Capital Leases | 0.00 | 0.29 | 0.28 | 0.27 | 0.27 | 0.28 | 0.25 | 0.25 | 0.25 | 0.25 | |
| Def. Tax Liability | 1.03 | 1.08 | 1.08 | 1.11 | 1.28 | 1.57 | 1.67 | 1.74 | 2.32 | 2.41 | |
| Total Liabilities | 22.70 | 22.84 | 22.82 | 22.87 | 24.96 | 25.81 | 27.33 | 27.22 | 27.88 | 27.85 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.27 | 0.27 | 0.27 | 0.27 | 0.26 | |
| Retained Earnings | 4.13 | 3.42 | 4.64 | 5.18 | 3.69 | 5.36 | 6.03 | 6.01 | 5.64 | 4.94 | 4.46 | 3.61 | 2.69 | 2.06 | 1.42 | 0.88 | |
| Comprehensive Income | -2.98 | -3.21 | -2.75 | -2.76 | -1.74 | -0.86 | -1.80 | -1.44 | -0.36 | -2.26 | -1.76 | -0.99 | -0.24 | -0.09 | -0.09 | 0.17 | |
| Total Common Equity | 19.52 | 18.64 | 20.47 | 21.07 | 20.49 | 22.95 | 11.88 | 12.17 | 13.31 | 11.12 | 9.76 | 3.26 | 2.94 | 3.34 | 3.49 | 3.60 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Retained Earnings | -0.05 | 0.08 | 0.23 | 3.42 | 4.08 | 4.13 | 4.61 | 4.64 | 5.55 | 5.37 | |
| Comprehensive Income | -2.71 | -2.66 | -2.87 | -3.21 | -2.69 | -2.98 | -2.94 | -2.75 | -3.21 | -3.01 | |
| Total Common Equity | 15.22 | 15.57 | 15.65 | 18.64 | 19.79 | 19.52 | 20.01 | 20.47 | 20.87 | 20.84 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 17.38 | 14.31 | 18.37 | 19.27 | 21.59 | 26.11 | 12.72 | 13.86 | 14.67 | 15.49 | 6.30 | 5.73 | 8.03 | 5.34 | 5.30 | 5.26 | |
| Book Value | 19.52 | 18.64 | 20.47 | 21.07 | 20.49 | 22.95 | 11.88 | 12.17 | 13.31 | 11.12 | 9.77 | 3.28 | 2.96 | 3.36 | 3.50 | 3.62 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Book Value | 15.22 | 15.57 | 15.65 | 18.64 | 19.79 | 19.52 | 20.01 | 20.47 | 20.87 | 20.84 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -0.65 | -3.51 | -0.63 | 0.05 | 2.08 | -1.27 | -0.67 | 0.02 | 0.35 | 0.70 | 0.48 | 0.85 | 0.93 | 0.63 | 0.64 | 0.54 | 0.35 | |
| Depreciation & Amortization | 2.80 | 2.80 | 2.71 | 2.74 | 3.03 | 4.51 | 2.22 | 2.02 | 2.11 | 1.81 | 1.52 | 1.03 | 0.57 | 0.52 | 0.55 | 0.51 | 0.42 | |
| Stock-Based Compensation | 0.18 | 0.18 | 0.15 | 0.18 | 0.12 | 0.11 | 0.08 | 0.06 | 0.00 | 0.07 | 0.09 | 0.09 | 0.07 | 0.05 | 0.04 | 0.04 | 0.03 | |
| Change Working Capital | -0.88 | -2.50 | -0.32 | -0.71 | -0.92 | -1.80 | -0.70 | -0.51 | -0.19 | -0.68 | -0.81 | -0.33 | -0.47 | -0.14 | -0.41 | -0.47 | -0.14 | |
| Change In Accounts Receivable | 0.04 | 0.33 | 0.30 | 0.08 | -0.24 | 0.06 | 0.08 | -0.02 | 0.34 | -0.16 | -0.13 | -0.27 | -0.94 | -0.55 | -0.35 | -0.32 | 0.02 | |
| Change In Accounts Payable | 0.18 | -0.17 | 0.04 | 0.31 | 0.17 | -0.07 | -0.08 | -0.10 | 0.22 | 0.01 | 0.09 | 0.13 | 0.00 | 0.14 | 0.08 | 0.13 | 0.02 | |
| Change In Inventories | -0.91 | -0.11 | -0.72 | -0.61 | -0.26 | -0.43 | -0.74 | -0.51 | -0.55 | -0.13 | -0.28 | -0.32 | -0.15 | -0.16 | -0.17 | -0.22 | -0.09 | |
| Other Non-cash Items | 4.86 | 5.84 | 1.17 | 0.92 | -1.32 | 0.80 | 0.52 | 0.41 | 0.34 | 0.28 | 1.37 | 0.48 | 0.24 | 0.15 | 0.23 | 0.16 | 0.26 | |
| Cash from Operations | 2.31 | 0.00 | 0.00 | 2.80 | 2.95 | 3.02 | 1.23 | 1.80 | 2.34 | 2.06 | 2.05 | 2.01 | 1.01 | 1.11 | 0.95 | 0.72 | 0.93 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -0.34 | -0.13 | 0.00 | -3.04 | -0.52 | 0.09 | -0.33 | 0.11 | -0.77 | 0.33 | |
| Depreciation & Amortization | 0.77 | 0.69 | 0.68 | 0.66 | 0.75 | 0.67 | 0.79 | 0.69 | 0.64 | 0.68 | |
| Stock-Based Compensation | 0.05 | 0.04 | 0.04 | 0.06 | 0.03 | 0.03 | 0.03 | 0.05 | 0.06 | 0.04 | |
| Change Working Capital | -1.43 | 0.13 | -0.98 | -0.22 | 0.15 | 0.14 | -0.21 | -0.19 | -0.28 | 0.01 | |
| Change In Accounts Receivable | 0.27 | -0.10 | -0.01 | 0.17 | 0.30 | -0.03 | 0.02 | 0.01 | 0.08 | -0.07 | |
| Change In Accounts Payable | 0.02 | 0.00 | -0.29 | 0.10 | 0.05 | -0.07 | -0.23 | 0.29 | 0.08 | 0.04 | |
| Change In Inventories | 0.02 | 0.11 | -0.04 | -0.19 | -0.04 | -0.13 | -0.19 | -0.37 | -0.13 | -0.22 | |
| Other Non-cash Items | 2.01 | 0.16 | 0.54 | 3.12 | 0.31 | 0.20 | 0.25 | 0.00 | 1.03 | -0.15 | |
| Cash from Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.48 | 0.82 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.42 | -0.38 | -0.33 | -0.38 | -0.44 | -0.51 | -0.68 | -0.41 | -1.20 | -0.90 | -0.75 | -0.87 | -0.75 | -0.33 | -0.31 | -0.28 | -0.19 | |
| Acquisitions | 0.89 | 0.00 | -0.35 | -0.67 | 0.00 | 0.28 | 0.42 | -0.15 | -0.07 | -0.17 | -6.61 | -0.69 | -0.05 | -1.26 | 0.02 | -0.08 | -0.56 | |
| Investments | -0.02 | -0.02 | -0.03 | -0.03 | -0.03 | -0.03 | -0.10 | -0.03 | -0.06 | -0.10 | -0.03 | -0.06 | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | |
| Sales of Investment | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.05 | 0.03 | 0.09 | 0.10 | 0.02 | 0.03 | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 | |
| Other Investing Activities | -0.19 | 0.00 | 0.00 | 0.28 | 1.96 | 0.12 | 0.02 | 0.03 | 0.03 | 0.16 | -0.25 | 0.02 | 0.00 | -0.26 | -0.07 | 0.04 | 0.03 | |
| Cash from Investing | 0.28 | 0.00 | 0.00 | -0.76 | 1.52 | -0.12 | -0.30 | -0.53 | -1.21 | -0.91 | -7.62 | -1.57 | -0.80 | -1.87 | -0.36 | -0.33 | -0.73 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.27 | -0.10 | -0.05 | -0.08 | -0.15 | -0.09 | -0.06 | -0.05 | -0.20 | -0.09 | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.44 | -0.35 | 0.36 | 0.00 | |
| Investments | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 | |
| Sales of Investment | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 | -0.04 | |
| Cash from Investing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 | -0.04 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -1.32 | 0.00 | 0.00 | -1.25 | -3.66 | -4.20 | -2.48 | -1.11 | -3.17 | -2.23 | -6.30 | -4.48 | -2.30 | -3.48 | -1.99 | -1.64 | -2.14 | |
| Debt Issued | 0.12 | 14.31 | -4.07 | 0.35 | 1.34 | -0.31 | 15.87 | -0.03 | 2.35 | 1.41 | 15.49 | 5.05 | 0.00 | 6.17 | 2.03 | 1.68 | 7.41 | |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10.73 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Repurchase of Common Stock | -0.26 | -0.50 | -0.25 | -0.25 | 0.00 | 0.00 | 0.00 | 0.00 | -0.43 | -0.50 | 0.00 | -0.07 | 0.00 | -1.00 | -1.00 | -0.35 | 0.00 | |
| Dividends Paid | -0.58 | 0.00 | 0.00 | -0.58 | -0.58 | -0.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.14 | |
| Other Financing Activities | -0.15 | 0.00 | 0.00 | -0.23 | 0.36 | 1.59 | -8.85 | -0.06 | 2.51 | 0.84 | 11.64 | 5.16 | 2.03 | 5.17 | 2.38 | 1.35 | 2.38 | |
| Cash from Financing | -2.30 | 0.00 | 0.00 | -2.30 | -3.88 | -3.01 | -0.61 | -1.17 | -1.09 | -1.89 | 5.34 | 0.60 | -0.27 | 0.69 | -0.61 | -0.64 | 0.10 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.50 | -0.02 | |
| Debt Issued | 14.72 | -0.04 | 0.30 | 0.15 | -1.72 | -1.36 | -0.83 | 0.09 | 0.25 | -0.21 | |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Repurchase of Common Stock | -0.09 | -0.07 | -0.18 | -0.18 | 0.00 | 0.00 | 0.00 | -0.25 | 0.00 | 0.00 | |
| Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.14 | -0.14 | |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.28 | 0.07 | |
| Cash from Financing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.93 | -0.10 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 0.29 | 0.61 | -0.26 | -0.27 | 0.56 | -0.14 | 0.36 | 0.10 | 0.02 | -0.71 | -0.24 | 1.01 | -0.07 | -0.06 | -0.03 | -0.29 | 0.28 | |
| Closing Cash Balance | 0.92 | 1.35 | 0.74 | 0.99 | 1.26 | 0.71 | 0.85 | 0.49 | 0.39 | 0.29 | 1.00 | 1.24 | 0.23 | 0.29 | 0.35 | 0.38 | 0.66 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 0.34 | 0.44 | -0.19 | 0.02 | -1.14 | 0.96 | -0.10 | 0.02 | -0.32 | 0.68 | |
| Closing Cash Balance | 1.35 | 1.00 | 0.57 | 0.76 | 0.74 | 1.88 | 0.92 | 1.02 | 0.99 | 1.31 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 1.88 | 1.94 | 1.98 | 2.33 | 2.51 | 2.51 | 0.55 | 1.40 | 1.15 | 1.17 | 1.30 | 1.14 | 0.26 | 0.77 | 0.64 | 0.44 | 0.74 | |
| Real Free Cash Flow | 1.70 | 1.76 | 1.83 | 2.14 | 2.39 | 2.40 | 0.47 | 1.34 | 1.15 | 1.09 | 1.21 | 1.04 | 0.19 | 0.73 | 0.60 | 0.40 | 0.71 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.55 | 0.65 | 0.17 | 0.46 | 0.33 | 0.74 | 0.32 | 0.56 | 0.28 | 0.73 | |
| Real Free Cash Flow | 0.50 | 0.61 | 0.13 | 0.40 | 0.30 | 0.71 | 0.29 | 0.52 | 0.22 | 0.69 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -4.3 | 41 | 2356.8 |
| P/S | 1.1 | 0.9 | 70.5 |
| P/B | 1 | 0.8 | 2015.4 |
| P/FCF | 9.3 | 9.5 | 7573.5 |
| Market cap | $11.6 | $13.7 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 38.8 % | 41.4 % | 0 % |
| Debt to Income | -418.9 % | 3976 % | 0 % |
| Debt to Free cash flow | 896.3 % | 9 % | 0 % |
| Interest expense percentage | -17.7 % | 89.1 % | 26.2 % |
| Current ratio | 1.3 | 1.6 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -23.1 % | 5.7 % | 0 % |
| ROA | -9.3 % | 1.5 % | 0 % |
| CapEx to Revenue | 2.7 % | 5.2 % | 6 % |
| RaD to Revenue | 0 % | 5.7 % | 0 % |
| ROEM | 446,871.9 | 7559.1 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 36.1 % | 39.6 % | 74.8 % |
| Operating margin | -18.2 % | 8 % | 35 % |
| Net margin | -26.1 % | 3.2 % | 34.1 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 1 % | 0 % |
| Dividend payout percentage | 0 % | 14.2 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 1,164.6 mil | 699.6 mil |
| Employee count | 32.0 tis | 12.8 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
